Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double-blind, placebo-controlled clinical trial

J Allergy Clin Immunol. 2018 Jan;141(1):448-451. doi: 10.1016/j.jaci.2017.09.013. Epub 2017 Oct 10.

¹ Immunomodulation and Tolerance group, Allergy and Clinical Immunology, Inflammation Repair & Development, MRC Asthma UK Centre Imperial College London, London, United Kingdom. Electronic address: m.shamji@imperial.ac.uk.
² Department of Allergy and Clinical Immunology, Leuven, Belgium.
³ Upper Airways Research Laboratory, Ghent University, Ghent, Belgium.
⁴ Ear, Nose and Throat Department, UZ Leuven, Leuven, Belgium.
⁵ ASIT Biotech, Brussels, Belgium.
⁶ Immunomodulation and Tolerance group, Allergy and Clinical Immunology, Inflammation Repair & Development, MRC Asthma UK Centre Imperial College London, London, United Kingdom.

No abstract available

Publication types